| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2005-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0adca7c8017f004a849f32b0b627a3b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec6162dd82750791b308625e8186de9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06accfd66e6ae9effd02ff15bf04ba57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b02a24f4c96a161a7d8f0e62e2c3cca |
| publicationDate |
2007-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20070036797-A |
| titleOfInvention |
Formulations with Enteric Coated Core Tablets |
| abstract |
The present invention provides a pharmaceutical formulation for oral administration to a patient, the pharmaceutical formulation comprising an enteric coated core tablet sheathed in an annulus of compressed powder or granular material. The invention also provides pharmaceutical formulations for simultaneous administration of two or more active pharmaceutical ingredients. The invention also provides a method comprising administering a formulation of the invention to a patient with gastric dyskinesia, such as a patient with Parkinson's disease. |
| priorityDate |
2004-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |